Tevis Investment Management Grows Stake in CME Group Inc. $CME

Tevis Investment Management lifted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 8.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,120 shares of the financial services provider’s stock after buying an additional 166 shares during the period. Tevis Investment Management’s holdings in CME Group were worth $584,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently bought and sold shares of the company. Wayfinding Financial LLC purchased a new position in CME Group during the first quarter valued at $25,000. Webster Bank N. A. lifted its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares in the last quarter. Cornerstone Planning Group LLC lifted its position in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 55 shares in the last quarter. Highline Wealth Partners LLC lifted its position in CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares in the last quarter. Finally, Golden State Wealth Management LLC lifted its position in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 98 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at CME Group

In other news, Director William R. Shepard bought 262 shares of CME Group stock in a transaction dated Thursday, September 25th. The shares were purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This trade represents a 0.10% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is owned by company insiders.

CME Group Price Performance

Shares of CME Group stock opened at $271.09 on Tuesday. The stock’s 50-day simple moving average is $266.48 and its 200-day simple moving average is $272.02. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The company has a market capitalization of $97.70 billion, a price-to-earnings ratio of 26.27, a PEG ratio of 6.65 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the business earned $2.68 earnings per share. The business’s revenue was down 3.0% on a year-over-year basis. As a group, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is 48.45%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CME. Oppenheimer lifted their target price on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Keefe, Bruyette & Woods lifted their target price on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research report on Monday, October 13th. TD Cowen boosted their price objective on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a research report on Thursday, October 23rd. Finally, Barclays lowered their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $284.53.

Check Out Our Latest Analysis on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.